Triterpene Acids from Frankincense and Semi-Synthetic Derivatives That Inhibit 5-Lipoxygenase and Cathepsin G
Authors:
- Andreas KoeberleAndreas Koeberle
- Arne HenkelAHArne Henkel
- Moritz VerhoffMVMoritz Verhoff
- Lars TauschLTLars Tausch
- Stefanie KönigSKStefanie König
- Dagmar FischerDFDagmar Fischer
- Nicole KatherNKNicole Kather
- Stefanie SeitzSSStefanie Seitz
- Michael PaulMPMichael Paul
- Johann JauchJJJohann Jauch
- Oliver WerzOWOliver Werz
Open Access
Abstract
Age-related diseases, such as osteoarthritis, Alzheimer’s disease, diabetes, and cardiovascular disease, are often associated with chronic unresolved inflammation. Neutrophils play central roles in this process by releasing tissue-degenerative proteases, such as cathepsin G, as well as pro-inflammatory leukotrienes produced by the 5-lipoxygenase (5-LO) pathway. Boswellic acids (BAs) are pentacyclic triterpene acids contained in the gum resin of the anti-inflammatory remedy frankincense that target cathepsin G and 5-LO in neutrophils, and might thus represent suitable leads for intervention with age-associated diseases that have a chronic inflammatory component. Here, we investigated whether, in addition to BAs, other triterpene acids from frankincense interfere with 5-LO and cathepsin G. We provide a comprehensive analysis of 17 natural tetra- or pentacyclic triterpene acids for suppression of 5-LO product synthesis in human neutrophils. These triterpene acids were also investigated for their direct interference with 5-LO and cathepsin G in cell-free assays. Furthermore, our studies were expanded to 10 semi-synthetic BA derivatives. Our data reveal that besides BAs, several tetra- and pentacyclic triterpene acids are effective or even superior inhibitors of 5-LO product formation in human neutrophils, and in parallel, inhibit cathepsin G. Their beneficial target profile may qualify triterpene acids as anti-inflammatory natural products and pharmacological leads for intervention with diseases related to aging.Keywords
This publication has 30 references indexed in Scilit:
- Increased Bioavailability of 11‐Keto‐β‐Boswellic Acid Following Single Oral Dose Frankincense Extract Administration After a Standardized Meal in Healthy Male Volunteers: Modeling and Simulation Considerations for Evaluating Drug ExposuresThe Journal of Clinical Pharmacology, 2012
- Boswellia serrataClinical Pharmacokinetics, 2011
- Inhibition of microsomal prostaglandin E2synthase‐1 as a molecular basis for the anti‐inflammatory actions of boswellic acids from frankincenseBritish Journal of Pharmacology, 2010
- Tirucallic Acids Are Novel Pleckstrin Homology Domain-Dependent Akt Inhibitors Inducing Apoptosis in Prostate Cancer CellsMolecular Pharmacology, 2010
- Identification of Human Cathepsin G As a Functional Target of Boswellic Acids from the Anti-Inflammatory Remedy FrankincenseThe Journal of Immunology, 2009
- Combined Lipoxygenase/Cyclo-oxygenase Inhibition in the ElderlyDrugs & Aging, 2005
- Coupling of boswellic acid‐induced Ca2+ mobilisation and MAPK activation to lipid metabolism and peroxide formation in human leucocytesBritish Journal of Pharmacology, 2004
- An Efficient Method for the Large‐Scale Preparation of 3‐O‐Acetyl‐11‐oxo‐β‐boswellic Acid and Other Boswellic AcidsEuropean Journal of Organic Chemistry, 2003
- Phosphorylation‐ and stimulus‐dependent inhibition of cellular 5‐lipoxygenase activity by nonredox‐type inhibitorsThe FASEB Journal, 2003
- Prostaglandins and Leukotrienes: Advances in Eicosanoid BiologyScience, 2001